04732nam 2200661 450 991013677410332120230921115129.01-118-94977-31-118-94976-5(CKB)3710000000635585(EBL)4462519(SSID)ssj0001639686(PQKBManifestationID)16399591(PQKBTitleCode)TC0001639686(PQKBWorkID)14808081(PQKB)10996490(MiAaPQ)EBC4462519(DLC) 2015040477(Au-PeEL)EBL4462519(CaPaEBR)ebr11189914(CaONFJC)MIL909469(OCoLC)925411014(PPN)243669410(EXLCZ)99371000000063558520151009d2016 uy| 0engur|n|---|||||txtccrDrug utilization research methods and applications /editors, Monique Elseviers [and twelve others]Chichester, West Sussex ;Hoboken, NJ :John Wiley & Sons Incorporated,2016.1 online resource (914 p.)THEi Wiley ebooksDescription based upon print version of record.1-118-94974-9 1-118-94978-1 Includes bibliographical references and index.Title Page; Copyright; List of contributors; Acknowledgements; Advisory board; Reviewers; About the companion website; Part 1: Introduction; Chapter 1: Introduction to drug utilization research; Room for improvement in drug utilization; The history of drug utilization research; Definition and delineation; Skills needed to be a drug utilization researcher; Areas of inquiry in drug utilization research reflected in this book; Part 2: Methodology; Chapter 2: Study designs in drug utilization research; Introduction; Quantitative and qualitative researchObservational studies: from descriptive to analytical approachesStudy designs for descriptive drug utilization studies; Study designs for analytical drug utilization studies; Experimental and quasiexperimental study designs in drug utilization research; Other study designs for drug utilization research; Chapter 3: Primary data collection for drug utilization research; Introduction; Identifying primary data sources for drug utilization research; Collecting valuable primary data in drug utilization research; Instruments and forms for primary data collection in drug utilization researchModes of primary data collection for drug utilization researchEthical considerations; Conclusion; Chapter 4: Secondary data sources for drug utilization research; Introduction; Sales data; Electronic health records; Pharmacy dispensing data; Reimbursement data; Patient registries; Secondary analysis of population health survey data; Record linkage in drug utilization research; Privacy, confidentiality and security; Data quality; Chapter 5: Classification systems for drugs and diseases; Introduction; ATC; Other drug classification systemsOther classification systems relevant for drug utilization researchLinkage of classification systems; Chapter 6: Measurement units of drug utilization; Introduction; DDD: definition and general considerations; Principles of DDD assignment; Alterations and misuse of DDDs; Other aggregate measures for prescribing; Other drug utilization metrics; Use of drugs in animals; How to report aggregated drug use; DDDs for special population groups; Chapter 7: Individual-level drug utilization analyses; Introduction; General principles; Epidemiological measures; Other measuresStrengths and limitations of individual-level statisticsChapter 8: Measurement of drug expenditure; Introduction; Definitions and perspectives; Price-related units of pharmaceutical expenditure; Methodological challenges related to pharmaceutical expenditure; Chapter 9: Basic statistical methods in drug utilization research; Introduction; Why we need statistical methods in drug utilization and health services research; Use of population data versus sample data; Types of variables; Describing data with descriptive statisticsInvestigating the difference between the means and medians of numerical variablesTHEi Wiley ebooks.Drug developmentMedicineResearchDrug development.MedicineResearch.615.1072/4Elseviers MoniqueMiAaPQMiAaPQMiAaPQBOOK9910136774103321Drug utilization research1960168UNINA